Gambaran Umum
Charles River Laboratories International, Inc., headquartered in Wilmington, Massachusetts, USA, is a prominent global company specialized in a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries. It facilitates drug discovery and development primarily by providing research models and associated services, and preclinical and clinical support to its partners. The company plays a pivotal role in pharmacology research, offering in vivo and in vitro testing, including safety assessments, biological assay development, and genetic testing. Through strategic acquisitions and global expansion, Charles River has broadened its capabilities and enhanced its position in the competitive contract research organization (CRO) market, supporting clients from early-stage drug discovery through to final product launch.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Charles River Laboratories International, Inc. per 2025 Jun 28 adalah 4,028.61 MM.
- Nilai operating income untuk Charles River Laboratories International, Inc. per 2025 Jun 28 adalah 534.92 MM.
- Nilai net income untuk Charles River Laboratories International, Inc. per 2025 Jun 28 adalah -67.04 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-28 | 4,028.61 | 534.92 | -67.04 |
2025-03-29 | 4,022.60 | 536.89 | -19.66 |
2024-12-28 | 4,049.99 | 545.86 | 22.20 |
2024-09-28 | 4,060.92 | 597.44 | 423.78 |
2024-06-29 | 4,077.78 | 633.45 | 441.51 |
2024-03-30 | 4,111.60 | 629.69 | 444.45 |
2023-12-30 | 4,129.41 | 651.79 | 474.62 |
2023-09-30 | 4,215.78 | 686.11 | 474.95 |
2023-07-01 | 4,178.31 | 660.27 | 484.03 |
2023-04-01 | 4,091.50 | 682.76 | 496.33 |
2022-12-31 | 3,976.06 | 665.51 | 486.23 |
2022-09-24 | 3,781.27 | 686.97 | 436.39 |
2022-06-25 | 3,688.05 | 690.59 | 443.35 |
2022-03-26 | 3,629.52 | 651.02 | 422.47 |
2021-12-25 | 3,540.16 | 634.39 | 390.98 |
2021-09-25 | 3,426.10 | 583.25 | 396.60 |
2021-06-26 | 3,273.46 | 556.58 | 396.08 |
2021-03-27 | 3,041.44 | 494.28 | 375.06 |
2020-12-26 | 2,923.93 | 439.07 | 364.30 |
2020-09-26 | 2,824.08 | 435.55 | 301.46 |
2020-06-27 | |||
2020-03-28 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-28 | ||
2025-03-29 | ||
2024-12-28 | 0.20 | 0.20 |
2024-09-28 | 8.03 | 8.00 |
2024-06-29 | 8.40 | 8.35 |
2024-03-30 | 8.55 | 8.50 |
2023-12-30 | 9.27 | 9.22 |
2023-09-30 | 9.29 | 9.22 |
2023-07-01 | 9.49 | 9.44 |
2023-04-01 | 9.75 | 9.68 |
2022-12-31 | 9.57 | 9.48 |
2022-09-24 | 8.61 | 8.50 |
2022-06-25 | 8.76 | 8.61 |
2022-03-26 | 8.37 | 8.20 |
2021-12-25 | 7.77 | 7.60 |
2021-09-25 | 7.91 | 7.72 |
2021-06-26 | 7.93 | 7.74 |
2021-03-27 | 7.54 | 7.36 |
2020-12-26 | 7.35 | 7.20 |
2020-09-26 | 6.11 | 6.00 |
2020-06-27 | 5.53 | 5.44 |
2020-03-28 | 5.06 | 4.98 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Charles River Laboratories International, Inc. per 2025 Jun 28 adalah 787.45 MM.
- Nilai cash from investing activities untuk Charles River Laboratories International, Inc. per 2025 Jun 28 adalah -180.25 MM.
- Nilai kas dari aktivitas pendanaan untuk Charles River Laboratories International, Inc. per 2025 Jun 28 adalah -615.66 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-28 | 787.45 | -180.25 | -615.66 |
2025-03-29 | 776.39 | -204.77 | -674.60 |
2024-12-28 | 734.58 | -245.09 | -550.93 |
2024-09-28 | 796.16 | -407.35 | -351.48 |
2024-06-29 | 749.82 | -465.59 | -306.81 |
2024-03-30 | 704.40 | -480.33 | -92.42 |
2023-12-30 | 683.90 | -563.15 | -85.52 |
2023-09-30 | 697.71 | -280.40 | -458.05 |
2023-07-01 | 625.04 | -293.03 | -346.77 |
2023-04-01 | 626.39 | -678.53 | -3.87 |
2022-12-31 | 619.64 | -607.92 | -42.40 |
2022-09-24 | 614.14 | -643.00 | -12.41 |
2022-06-25 | 656.08 | -905.86 | 218.08 |
2022-03-26 | 693.20 | -1,397.94 | 464.60 |
2021-12-25 | 760.80 | -1,437.93 | 672.60 |
2021-09-25 | 669.92 | -1,535.66 | 832.34 |
2021-06-26 | 672.50 | -1,251.42 | 384.81 |
2021-03-27 | 648.21 | -325.86 | -237.24 |
2020-12-26 | 546.58 | -601.54 | 47.25 |
2020-09-26 | 588.87 | -583.99 | 67.43 |
2020-06-27 | |||
2020-03-28 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-28 | |||
2025-03-29 | |||
2024-12-28 | |||
2024-09-28 | |||
2024-06-29 | |||
2024-03-30 | |||
2023-12-30 | |||
2023-09-30 | |||
2023-07-01 | |||
2023-04-01 | |||
2022-12-31 | |||
2022-09-24 | |||
2022-06-25 | |||
2022-03-26 | |||
2021-12-25 | |||
2021-09-25 | |||
2021-06-26 | |||
2021-03-27 | |||
2020-12-26 | |||
2020-09-26 | |||
2020-06-27 | |||
2020-03-28 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-28 | ||
2025-03-29 | ||
2024-12-28 | ||
2024-09-28 | ||
2024-06-29 | ||
2024-03-30 | ||
2023-12-30 | ||
2023-09-30 | ||
2023-07-01 | ||
2023-04-01 | ||
2022-12-31 | ||
2022-09-24 | ||
2022-06-25 | ||
2022-03-26 | ||
2021-12-25 | ||
2021-09-25 | ||
2021-06-26 | ||
2021-03-27 | ||
2020-12-26 | ||
2020-09-26 | ||
2020-06-27 | ||
2020-03-28 |
Efektivitas Manajemen
- roa untuk Charles River Laboratories International, Inc. pada 2025 Jun 28 adalah -0.00.
- roe untuk Charles River Laboratories International, Inc. pada 2025 Jun 28 adalah -0.01.
- roic untuk Charles River Laboratories International, Inc. pada 2025 Jun 28 adalah -0.00.
- croic untuk Charles River Laboratories International, Inc. pada 2025 Jun 28 adalah -0.02.
- ocroic untuk Charles River Laboratories International, Inc. pada 2025 Jun 28 adalah 0.12.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-28 | -0.00 | -0.01 | -0.00 | -0.02 | 0.12 |
2025-03-29 | 0.00 | 0.01 | 0.00 | -0.01 | 0.12 |
2024-12-28 | 0.06 | 0.13 | 0.06 | 0.01 | 0.12 |
2024-09-28 | 0.06 | 0.13 | 0.07 | -0.00 | 0.11 |
2024-06-29 | 0.06 | 0.14 | 0.07 | 0.02 | 0.10 |
2024-03-30 | 0.06 | 0.16 | 0.07 | 0.01 | 0.10 |
2023-12-30 | 0.06 | 0.18 | 0.08 | -0.00 | 0.11 |
2023-09-30 | 0.07 | 0.18 | 0.08 | 0.00 | 0.10 |
2023-07-01 | 0.07 | 0.18 | 0.08 | -0.01 | 0.10 |
2023-04-01 | 0.07 | 0.18 | 0.08 | -0.00 | 0.10 |
2022-12-31 | 0.06 | 0.17 | 0.07 | -0.01 | 0.10 |
2022-09-24 | 0.07 | 0.19 | 0.07 | -0.00 | 0.11 |
2022-06-25 | 0.07 | 0.19 | 0.07 | -0.04 | 0.12 |
2022-03-26 | 0.07 | 0.18 | 0.07 | 0.00 | 0.14 |
2021-12-25 | 0.08 | 0.21 | 0.07 | -0.00 | 0.12 |
2021-09-25 | 0.08 | 0.22 | 0.07 | -0.03 | 0.13 |
2021-06-26 | 0.07 | 0.22 | 0.08 | 0.02 | 0.14 |
2021-03-27 | 0.08 | 0.22 | 0.08 | -0.00 | 0.13 |
2020-12-26 | 0.07 | 0.19 | 0.07 | 0.02 | 0.14 |
2020-09-26 | 0.06 | 0.18 | 0.06 | 0.05 | 0.13 |
2020-06-27 | 0.06 | 0.17 | 0.06 | 0.06 | 0.13 |
2020-03-28 | 0.07 | 0.19 | 0.07 | 0.01 | 0.13 |
Gross Margins
- marjin kotor untuk Charles River Laboratories International, Inc. pada 2025 Jun 28 adalah 0.35.
- marjin bersih untuk Charles River Laboratories International, Inc. pada 2025 Jun 28 adalah -0.00.
- marjin operasi untuk Charles River Laboratories International, Inc. pada 2025 Jun 28 adalah 0.14.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-28 | 0.35 | -0.00 | 0.14 |
2025-03-29 | 0.33 | 0.01 | 0.11 |
2024-12-28 | 0.37 | 0.10 | 0.16 |
2024-09-28 | 0.36 | 0.11 | 0.16 |
2024-06-29 | 0.37 | 0.11 | 0.15 |
2024-03-30 | 0.36 | 0.11 | 0.15 |
2023-12-30 | 0.37 | 0.11 | 0.16 |
2023-09-30 | 0.37 | 0.12 | 0.16 |
2023-07-01 | 0.37 | 0.12 | 0.17 |
2023-04-01 | 0.37 | 0.12 | 0.16 |
2022-12-31 | 0.37 | 0.12 | 0.19 |
2022-09-24 | 0.37 | 0.12 | 0.20 |
2022-06-25 | 0.38 | 0.12 | 0.18 |
2022-03-26 | 0.38 | 0.11 | 0.17 |
2021-12-25 | 0.38 | 0.12 | 0.17 |
2021-09-25 | 0.38 | 0.12 | 0.17 |
2021-06-26 | 0.37 | 0.12 | 0.16 |
2021-03-27 | 0.37 | 0.12 | 0.15 |
2020-12-26 | 0.37 | 0.11 | 0.15 |
2020-09-26 | 0.36 | 0.10 | 0.14 |
2020-06-27 | 0.37 | 0.09 | 0.14 |
2020-03-28 | 0.37 | 0.10 | 0.13 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1100682 |
Grupong Pang-industriya
SIC 8731 - Commercial Physical and Biological Research |